Search Results
All Content Formulary Only Other ContentWe have found 20 results when searching "Levetiracetam"
PATHWAY
Epilepsy : General prescribing notes for all paediatric pathways
Epilepsy is broadly classified into either focal or generalized syndromes. It is important for treatment to distinguish where possible between genetic generalized epilepsy (GGE, previously known as id...
FORMULARY DECISION
Levetiracetam : Keppra
150/04 : Epilepsy. See link to SMC advice for full details of restriction.
FORMULARY DECISION
Levetiracetam : Keppra
151/04 : Epilepsy. See link to SMC advice for full details of restriction.
FORMULARY DECISION
Levetiracetam : Keppra
311/06 : Epilepsy
FORMULARY DECISION
Levetiracetam : Keppra
394/07 : Adjunctive therapy in treatment of partial onset seizures with or without sedondary generalisation in children from 4 years of age with epilepsy
FORMULARY DECISION
Levetiracetam : Keppra
395/07 : Adjunctive therapy in treatment of myclonic seizures in adults and adolescents from 12 years of age with juvenile muclonic epilepsy
FORMULARY DECISION
Levetiracetam : Keppra
396/07 : Adjunctive therapy in treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with generalised idiopathic epilepsy
FORMULARY DECISION
Levetiracetam : Keppra
397/07 : Monotherapy for epilepsy
FORMULARY DECISION
Levetiracetam : Keppra
661/10 : Adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in children and infants from 1 month of age to 4 years with epilepsy